Atlas Trials

A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma

Clinical trial NCT05712083 · UNKNOWN

Trial details

NCT number
NCT05712083
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaNew Diagnosis Tumor
Start date
2023-01-30
Primary completion
2024-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.